MF
VIR icon

Magnetar Financial’s Vir Biotechnology VIR Stock Holding History

Magnetar Financial’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-41,891
Closed -$314K – 798
2024
Q3 		$314K Buy
41,891
+31,223
+293% +$271K 0.01% 400
2024
Q2 		$94.9K Buy
+10,668
New +$102K ﹤0.01% 487
2023
Q2 		– Sell
-9,954
Closed -$232K – 625
2023
Q1 		$232K Buy
+9,954
New +$255K ﹤0.01% 537
2022
Q1 		– Sell
-21,127
Closed -$885K – 1541
2021
Q4 		$885K Buy
+21,127
New +$828K 0.01% 833

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return